Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSULET CORPPODD · Entity 3516 | EVP, CFO | July 03, 2023 | July 06, 2023 |
| Solventum CorpSOLV · Entity 1645 | Chief Financial Officer | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSULET CORP
Report date July 03, 2023 · Filed July 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,477 |
Reported balance
After 2023-07-03 transaction · row 1
1 source rowRow 1 · 2023-07-03 · Sale · Disposed 1,388 · Balance 21,477 F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $281.15 to $286.61. Specifically: 503 shares were sold in the range of $281.15 to $281.79, with a weighted average share price of $281.53; 210 shares were sold in the range of $282.37 to $283.37, with a weighted average share price of $283.01; F2: Footnote continued: 588 shares were sold in the range of $283.44 to $284.39 with a weighted average share price of $283.81; 70 shares were sold at a price of $284.70; and 17 shares were sold at a price of $286.61. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $281.15 to $286.61. Specifically: 503 shares were sold in the range of $281.15 to $281.79, with a weighted average share price of $281.53; 210 shares were sold in the range of $282.37 to $283.37, with a weighted average share price of $283.01;
F2: Footnote continued: 588 shares were sold in the range of $283.44 to $284.39 with a weighted average share price of $283.81; 70 shares were sold at a price of $284.70; and 17 shares were sold at a price of $286.61. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Solventum Corp
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,637 |
Ending reported balance
After 2026-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-13 · Exercise / conversion · Acquired 9,503 · Balance 53,041 Row 2 · 2026-05-13 · Tax withholding · Disposed 4,404 · Balance 48,637 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2034-05-13 | Direct | 9,504 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Exercise / conversion · Disposed 9,503 · Balance 9,504 F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 4,932 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F2: At the Effective Time, each time-vesting restricted stock unit award (a "Company RSU Award") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.27 · Expires 2035-04-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 5,171 · Balance 0 F3: For Footnote (3), see Remarks below. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F2: At the Effective Time, each time-vesting restricted stock unit award (a "Company RSU Award") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F3: For Footnote (3), see Remarks below.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2021 Filed Feb 19, 2021 21:19 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006744 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,126 F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:27 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 202 | $280.15 | $56,590.30 |
DisclosureSEC source: 0001127602-21-005242 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,562 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:46 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 2,512 | $189.97 | $477,204.64 |
DisclosureSEC source: 0001127602-20-008600 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,764 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 22:18 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 363 | $180.01 | $65,343.63 |
DisclosureSEC source: 0001127602-20-008178 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,276 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:56 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,411 | $0.00 Strike: $202.64 | $0.00 |
DisclosureSEC source: 0001127602-20-005089 · form4.xml · derivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,411 Underlying: Common Stock · 5,411 shares Expires 2030-02-10 F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:56 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005089 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,639 F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 00:10 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 21,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-010068 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,727 F1 · shares: The 21,198 restricted stock units vest one-third of the total units on March 1, 2020, one-third of the total units on March 1, 2021, and one-third of the total units on March 1, 2022, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 3,529 restricted stock units granted on February 26, 2019, which vest one-third of the total units on February 26, 2020, one-third of the total units on February 26, 2021, and one-third of the total units on February 26, 2022, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.